Drugmakers prepare to sue EU over tax to pay for waste water clean-up - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
污染

Drugmakers prepare to sue EU over tax to pay for waste water clean-up

Pharma and cosmetics industries want other sectors to contribute ‘fair share’ towards cost of removing pollutants
00:00

{"text":[[{"start":9.79,"text":"Drugmakers are preparing to sue the EU over a new tax to pay to clean up polluted waste water, arguing other industries should also have to foot the bill. "}],[{"start":20.53,"text":"The new rule, which came into force at the start of the year, requires the pharmaceutical and cosmetics industries to pay at least 80 per cent of the cost of removing pollutants such as microplastics and chemicals from urban waste water. "}],[{"start":35.83,"text":"The European Commission has estimated the cost at about €1.2bn a year, but the German environment agency suggested it could cost up to €1.25bn to improve wastewater treatment in Germany alone. "}],[{"start":51.75,"text":"The directive targets household waste water that has been polluted by medicines excreted in urine or by washed-off cosmetics, rather than factory waste water. "},{"start":61.879,"text":"It aims to protect health and the environment from the effects of such micropollutants, directing towns and cities across the bloc to remove them using an advanced process known as “quaternary treatment”. "}],[{"start":74.49,"text":"But the pharma industry lobby group is preparing a lawsuit that will argue that the directive breaks EU treaties on proportionality, non-discrimination and the principle of “polluter pays”, given other industries also contribute to pollutants in the water. "}],[{"start":90.97999999999999,"text":"The list of micropollutants the EU is targeting also includes plastics, pesticides, artificial sweeteners and illegal drugs. "}],[{"start":100.32,"text":"Nathalie Moll, director-general of the European Federation of Pharmaceutical Industries and Associations, said the organisation did not know why the EU has decided to target two sectors when others also contributed to the problem. "}],[{"start":115.80999999999999,"text":"“We are looking for a fair share of the costs being paid by all the polluting industries,” she said, adding this would not only share the financial burden, but create incentives for everyone to produce more sustainable products. "}],[{"start":130.04999999999998,"text":"“Our industry supports the ambition of the legislation and is 100 per cent committed to paying its fair share,” she added. "}],[{"start":138.71999999999997,"text":"The European Commission said: “Cosmetic and pharmaceutical residues represent the main sources of persistent micropollutants, mainly stemming from households, found in urban wastewater. "},{"start":150.51199999999997,"text":"Without the residues of these two sectors, there would not be a need for additional, quaternary treatment in urban wastewater facilities. ”"}],[{"start":159.65999999999997,"text":"It added that the system was “proportionate” and that it expects exemptions for smaller and medium companies with only limited sales in Europe or products that do not pollute. "}],[{"start":170.89999999999998,"text":"The updated directive comes as drugmakers push back against EU measures that could reduce the length of drug patents, as part of a major overhaul of industry regulation. "},{"start":181.62899999999996,"text":"They are also increasingly worried about the risk of tariffs on imports into the US, the industry’s largest and most profitable market. "}],[{"start":190.61999999999998,"text":"Several EU member states, including Bulgaria and the Czech Republic, have written to the Council of the European Union to express concern about the impact of the new waste water rule on drug prices, in case the industry passes on the costs to consumers and healthcare systems. "}],[{"start":207.59999999999997,"text":""}]],"url":"https://d33mkcasurz97s.cloudfront.net/album/195119-1741003178.mp3"}

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

为什么AI很难发现新药?

上一代初创企业未能兑现当时的夸张宣传。企业高管如今押注更强大的AI工具将攻克人体生物学的复杂难点。

现代汽车:卷入美国移民突袭风暴的车企

这家试图助力美国制造业发展的韩国企业,正面临特朗普加征的更高关税,并在韩国国内面临罢工。

欧洲对德拉吉方案推进缓慢

意大利前总理德拉吉发布竞争力报告一年后,欧盟仅落实了其想法的11.2%。

瑞穗CEO:瑞穗具备跻身全球前十投行的“所有要素”

在完成对格林希尔的整合后,这家日本集团已准备好在美国市场迎战美国竞争对手。

SpaceX巧妙闯入投资者“轨道”

EchoStar从濒临破产,摇身一变成为押注全球最大“独角兽”的间接途径。

石油巨头因油价低迷大幅削减工作岗位与投资

石油业高管们准备迎接可能将持续多年的低迷期。
设置字号×
最小
较小
默认
较大
最大
分享×